AI assistant
Sending…
PegBio Co., Ltd. — Earnings Release 2004
Dec 24, 2003
50676_rns_2003-12-24_016426bb-1bbf-4c87-a38c-2216c9799ccd.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| XIN CORP<01141> - Results Announcement Xin Corporation Limited announced on 24/12/2003: (stock code: 01141 ) Year end date: 31/3/2004 Currency: HKD Auditors' Report: N/A Interim report reviewed by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 1/4/2003 from 1/4/2002 to 30/9/2003 to 30/9/2002 Note ('000 ) ('000 ) Turnover : 11,862 22,947 Profit/(Loss) from Operations : (12,102) 63,593 Finance cost : (3,295) (2,841) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (15,397) 60,752 % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.05) 0.26 -Diluted (in dollars) : N/A 0.23 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (15,397) 60,752 Interim Dividend : Nil Nil per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. TURNOVER Turnover represents net invoiced value of goods sold, after allowances for returns and trade discounts. 2. PROFIT/(LOSS) FROM OPERATING ACTIVITIES The Group's profit/(loss) from operating activities for the period is arrived at after charging/(crediting): Six months ended 30 September 2003 2002 (Unaudited) (Unaudited) HK$'000 HK$'000 Depreciation 5,257 7,486 Staff costs 5,143 6,554 Waiver of debts due to bankers and creditors - (77,051) ====== ======= 3. EARNINGS/(LOSS) PER SHARE The calculation of basic loss per share is based on the unaudited consolidated net loss from ordinary activities attributable to shareholders for the six months ended 30 September 2003 of HK$15,397,000 (2002: net profit of HK$60,752,000) and the weighted average of 335,812,912 (2002 (restated): 230,996,772) ordinary shares of the Company in issue during the period. The comparative number of shares used for the calculation of basic loss per share has also been adjusted to reflect the share consolidation on 30 December 2002 and the open offer on 24 September 2003. Diluted loss per share for the six months ended 30 September 2003 has not been disclosed, as the potential ordinary shares outstanding during the period had an anti-dilutive effect on the basic loss per share for that period. The calculation of diluted earnings per share for the six months ended 30 September 2002 is based on the adjusted net profit of HK$60,958,000 (after adjusted for the interest expenses of approximately HK$206,000 saved if all convertible bonds and note were converted to the Company's shares at their issuing dates) and the weighted average number of 260,483,211 ordinary shares in issue (restated) (after adjusted for the share consolidation on 30 December 2002 and the open offer on 24 September 2003). |
More from PegBio Co., Ltd.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 19
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 6
